Prospective Follow-up of Outcomes in Patients Receiving Photodynamic Therapy for Neoplastic Diseases

Active, not recruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Neoplastic Disease
Interventions
OTHER

Data Collection

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT02159742 - Prospective Follow-up of Outcomes in Patients Receiving Photodynamic Therapy for Neoplastic Diseases | Biotech Hunter | Biotech Hunter